How to buy OptiNose stock - 11 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy OptiNose stock

Own OptiNose stock in just a few minutes.

OptiNose, Inc is a drug manufacturers-specialty & generic business based in the US. OptiNose shares (OPTN) are listed on the NASDAQ and all prices are listed in US Dollars. OptiNose employs 204 staff and has a trailing 12-month revenue of around USD$49.1 million.

How to buy shares in OptiNose

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for OptiNose. Find the stock by name or ticker symbol: OPTN. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OptiNose reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of OptiNose, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of OptiNose. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

OptiNose share price

Use our graph to track the performance of OPTN stocks over time.

OptiNose shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$3.14 - USD$7.1
50-day moving average USD$3.7632
200-day moving average USD$4.0444
Wall St. target priceUSD$16
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-2.611

Buy OptiNose shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OptiNose stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OptiNose financials

Revenue TTM USD$49.1 million
Gross profit TTM USD$41.6 million
Return on assets TTM -30.16%
Return on equity TTM -291.89%
Profit margin -203.16%
Book value $0.128
Market capitalisation USD$184.3 million

TTM: trailing 12 months

Shorting OptiNose shares

There are currently 4.3 million OptiNose shares held short by investors – that's known as OptiNose's "short interest". This figure is 10% down from 4.8 million last month.

There are a few different ways that this level of interest in shorting OptiNose shares can be evaluated.

OptiNose's "short interest ratio" (SIR)

OptiNose's "short interest ratio" (SIR) is the quantity of OptiNose shares currently shorted divided by the average quantity of OptiNose shares traded daily (recently around 559228.99869961). OptiNose's SIR currently stands at 7.69. In other words for every 100,000 OptiNose shares traded daily on the market, roughly 7690 shares are currently held short.

However OptiNose's short interest can also be evaluated against the total number of OptiNose shares, or, against the total number of tradable OptiNose shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case OptiNose's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 OptiNose shares in existence, roughly 80 shares are currently held short) or 0.1399% of the tradable shares (for every 100,000 tradable OptiNose shares, roughly 140 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against OptiNose.

Find out more about how you can short OptiNose stock.

OptiNose share dividends

We're not expecting OptiNose to pay a dividend over the next 12 months.

OptiNose share price volatility

Over the last 12 months, OptiNose's shares have ranged in value from as little as $3.14 up to $7.1. A popular way to gauge a stock's volatility is its "beta".

OPTN.US volatility(beta: 1.01)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OptiNose's is 1.0066. This would suggest that OptiNose's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

OptiNose overview

OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase 3b clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It is also developing OPN-019 that combines liquid EDS device with an antiseptic. The company has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail; and Inexia Limited to develop, manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2000 and is headquartered in Yardley, Pennsylvania.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site